Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine
Xiaoshuo Dai, Wei Chen, Yan Qiao, Xinhuan Chen, Yihuan Chen, Kai Zhang, Qiushuang Zhang, Xiaoxuan Duan, Xiang Li, Jimin Zhao, Fang Tian, Kangdong Liu, Ziming Dong, Jing Lü
Topics & Concepts
DihydroartemisininPharmacologyColorectal cancerCapecitabineMMP9MetastasisMedicineAngiogenesisCancer researchToxicityCancerChemistryInternal medicineDownregulation and upregulationImmunologyBiochemistryArtemisininPlasmodium falciparumMalariaGeneCancer Mechanisms and TherapyPeptidase Inhibition and AnalysisSignaling Pathways in Disease